Patent · US Active

PPAR gamma agonists for treatment of multiple sclerosis

US9061020B2 · kind B2 · utility

9Cited by
1References
4Claims
0Family size

Assignee

Inventor

Key dates

Filing dateJan 23, 2014
Grant dateJun 23, 2015
Priority date—
Expiry dateJan 23, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/28
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods of treatment of multiple sclerosis (MS) with PPARγ agonists, and in particular with the compound of formula (I) known as INT131:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.